JPH203 is a potent and selective small inhibitor for LAT1 and its robust anti-tumor activity is now examined in a clinical trial for colorectal cancer, biliary tract cancer, and pancreatic cancer20. This evidence concerns the gene SLC7A5 and neoplasm.